Basser Research Center for BRCA

Basser Global Prize

To further enhance the Basser Center's mission, the Basser Global Prize was established by Shari Basser Potter and Leonard Potter to honor a visionary scientist who has conceptually advanced BRCA1/2 related research that has led to improvements in clinical care. The prize will be considered for a broad range of basic, translational and clinical BRCA1/2 cancer researchers worldwide. Outstanding candidates will be those whose research has produced seminal advances in the field and who continue to drive BRCA1/2 related research towards the ultimate goal of mitigating the adverse impact of deleterious BRCA1/2 and related mutations.
 

The Basser Global Prize provides $200,000 in unrestricted support of the awardee's innovative BRCA1/2 related research efforts. The Awardee will give the Keynote address at the annual Basser Research Center for BRCA Symposium the following year, at which time they will be awarded the Basser trophy and a personal $10,000 cash prize by the Gray and Potter Families.

The winner of the 2014 Basser Global Prize is Dr. Mary-Claire King, from the University of Washington in Seattle. Dr. King is known worldwide for her major accomplishments in human genetics research and one of her most noteworthy achievements is the identification of the BRCA1 gene. This year marks the 20th anniversary of the identification of the gene.

“I am honored to be recognized with this award from the Basser Research Center for BRCA,” said Mary-Claire King, PhD, American Cancer Society Research Professor of Medicine and Genome Sciences at the University of Washington in Seattle. “The advances stemming from the discovery of BRCA1 twenty years ago have provided both the possibility of prevention for women with inherited mutations in BRCA1 or BRCA2 and hope of new treatment options for patients diagnosed with inherited breast and ovarian cancer. With support from organizations like the Basser Center, we will continue to see huge improvements in the prevention and treatment of breast and ovarian cancer.”

Read the 2014 Basser Global Prize press release here.

Click here to read about past Basser Global Prize winners.

The Basser Global Prize Application Process

Eligibility

Nominees are not restricted to any geographic area or type of institution. The appropriate Institutional Official (e.g. Chancellor, Dean or Provost) must nominate applicants. Self-nominations will not be accepted.

The following must be included in the Nomination Package:

  • Basser Global Prize Application Form including:

    • Nominee and Institutional Official contact information and signatures

    • Summary Statement of Major Research Accomplishments (500 words maximum)
      This statement should summarize and succinctly state the major research accomplishments of the nominee, with a particular emphasis on how these findings have advanced BRCA1/2 related research. Accomplishments can span basic biology, diagnosis, treatment and outcomes for BRCA1/2 carriers and their families.

    • Listing of five most important publications related to BRCA1/2 research (250 words maximum, each)
      Provide a description of the importance of each publication.

    • Vision for future BRCA1/2 research (1,000 words maximum) The Nominee will describe a broad vision of her/his research program over the next 5 years.
  • Nominee's CV

  • Nominating letter (1 page)
    The Institutional Official will describe the major accomplishments of the nominee and why this individual warrants consideration for the Basser Global Prize.
 

 

Patients

The Basser Research Center for BRCA website contains up-to-date, expert-reviewed information on BRCA1 and BRCA2 education & support.

Learn More

Investigators & Clinicians

The Basser Research Center for BRCA provides grant funding opportunities for researchers working on BRCA1 and BRCA2

Learn More

Ways to Give

Philanthropy helps to provide essential resources to support the Center's mission to improve the lives of individuals with BRCA1 and BRCA2 mutations.

Donate Now